Skip to main content ( press enter )

Latest News

 Stay up-to-date on the latest cancer research, fundraising news, and general news from Peter Mac. 

General News

How an innovative clinical treatment helped Stuart defy a stage 4 prostate cancer prognosis

A shock diagnosis of advanced prostate cancer turned Stuart’s life upside down.  In March 2022, Stuart went in for his annual men’s health check as he’d always done. He was feeling good, living...Read more

5 minutes min read 17 June 2026
4 June 2026
General News

Ritchies IGA: supporting cancer research at Peter Mac for over 33 years
2 June 2026
Announcement

New fellowship strengthening our care for young people at Peter Mac

25 May 2026
Patient

Surviving advanced melanoma: Alex’s story of treatment, research and hope
8 May 2026
General News

Rosemary’s cancer story: hope, family and gratitude
6 May 2026
Fundraising

$338,635 raised for cancer research as Peter Mac Cup 2026 unites rivals

@Follow us on Instagram (@SupportPeterMac)

At Peter Mac, breakthroughs are underway – targeting rare cancers with powerful treatments that save lives without taking so much from them. Associate Professor Ian Parish is leading efforts to understand how immunotherapy can be adapted for cancers like sarcoma. He and his team are exploring how to harness the body’s own defences to do everything they’re capable of. While success is seen in some cancers, there is still much to uncover for rare cancers – a challenge given the fewer patient cases and tumour samples. 💬 “Patterns only emerge when enough evidence is gathered across many patients”, says A/ Prof Ian Parish. For people living with rare cancers like sarcoma, the potential impact is profound: a future where treatments are strong where they need to be, and gentler everywhere else. 💜 Your support can help turn possibility into progress – bringing better options within reach for people with rare cancers. Read more on Associate Professor Ian Parish’s work: foundation.petermac.org/aprof-ian
“Don’t wait for the signs. I didn’t have any, and other men have said exactly the same thing to me.” This Men’s Health Week, we share Stuart’s prostate cancer journey. Although he’d had no symptoms and had lived a healthy life, Stuart’s world was turned upside down when a standard men’s health check led to a Stage 4 prostate cancer diagnosis. The outlook was dire. After about a year of hormone therapy and chemotherapy, Stuart was running out of options. Fortunately, a pioneering new clinical treatment program at Peter Mac gave Stuart renewed hope and more time. These days, Stuart lives a healthy and happy life filled with gratitude. He encourages other men to undertake their annual health checks, and to seek support during their cancer journeys. “We need to talk about it. If I held everything in, I’d be no good to myself or my family.” Read Stuart’s story at the link in bio.
For over 33 years now, @ritchiessupermarkets has generously supported lifesaving cancer research at Peter Mac. A household name with the community at its heart, Ritchies IGA allows customers to support a charity of their choice via their Community Benefits Program with their purchases. And thanks to the many kind customers who have nominated Peter Mac as their charity, Ritchies has gifted a wonderful $434,000 towards shaping a more hopeful future for people with cancer. To read about how Ritchies is making a difference for cancer treatment and care – and how you can support Peter Mac every time you shop with Ritchies – visit the link in bio. @petermaccancercentre
Young people with cancer now have access to more specialised care. A new program at Peter Mac, made possible by @myroomccc , is helping transform outcomes for patients aged 15–25. A group with their own unique challenges. The My Room Adolescent and Young Adult Cancer Fellowship is providing dedicated training for oncologists to better support this age group. We’re proud to partner with My Room, whose unwavering commitment ensures every young person has a fighting chance. Read more via the link in bio
Imagine surviving cancer without losing so much along the way. For Ada, that meant losing her leg. Diagnosed with osteosarcoma at just 18, Ada had no idea what was to come. After undergoing nine months of chemotherapy, the conversation turned to surgery: amputating her leg above the knee to protect her long-term future. 💬 “No one wants to lose their limbs, but if it’s to reduce the cancer coming back... that’s how I thought of it”, she says. Today, Ada wears her pink and blue prosthetic with pride. But what if treatment didn’t have to take so much from people in the first place? Immunotherapy offers that possibility. Researchers at Peter Mac are exploring how to harness it for rare cancers like osteosarcoma — complex work that relies on sustained support. ⭐ Because gentler treatments don’t just save lives. They protect futures. Read more of Ada’s story: foundation.petermac.org/ada
Back to top